POTS common in patients with long COVID
A new study from Karolinska Institutet in Sweden shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those affected are middle-aged women. The study is published in the scientific journal Circulation: Arrhythmia and Electrophysiology.

Postural orthostatic tachycardia syndrome, or POTS, is a condition where the heart beats abnormally fast when changing position from lying down to standing up. Standing up is a challenge for those affected who feel dizzy and would rather sit or lie down, so called orthostatic intolerance. Their hearts may also beat faster than normal at rest and during exertion. Patients experience fatigue and difficulties concentrating, symptoms that are common in long COVID.
Now, researchers at Karolinska Institutet show that POTS occurs in almost a third of patients with severe long COVID. By comparison, less than one per cent of the Swedish population was affected by POTS before the pandemic.
"Previous, smaller studies have shown that there is a connection, but now we can say with certainty that POTS is a very common condition in patients with long COVID. This is valuable knowledge for both healthcare professionals and patients," says Mikael Björnson, doctoral student at the Department of Medicine, Solna, Karolinska Institutet.
Women in their early middle age
According to the researchers, this study is the largest and most detailed to date on the link between POTS and long COVID. A total of 467 patients with severe long COVID who had not been hospitalised for COVID-19 were examined. Ninety-one per cent were middle-aged women who were essentially healthy and physically active before they developed long COVID. At an average of twelve months after falling ill, they underwent physical tests and completed forms about their health. Those who showed signs of possible POTS also received an assessment from a cardiologist after further, targeted tests.
Thirty-one per cent of participants received a POTS diagnosis, while 27 per cent had symptoms but did not meet the criteria for diagnosis. The remaining 42 per cent had no symptoms of POTS. Patients with a diagnosis had significantly higher heart rates during walking tests and reported lower health-related quality of life.
POTS can be treated
“It is important to know that POTS can be detected with inexpensive, simple tests that are available at all levels of healthcare. For those who receive a diagnosis, there are treatments that can alleviate symptoms and improve quality of life,” says Judith Bruchfeld, associate professor at Karolinska Institutet, senior consultant in infectious diseases at Karolinska University Hospital, and head of the study.
The researchers now recommend that patients with long COVID who experience a significant increase in heart rate when changing position from lying down to standing, as well as during exertion, and who experience symptoms such as dizziness, brain fog and pronounced fatigue, are investigated for POTS.
The next step in the research is a four- and five-year follow-up of the patient group, and in addition, patients with COVID-19 who have been treated in hospital. The researchers will investigate recovery and functional level over time.
The study is a collaboration with Karolinska University Hospital and has been funded by the Swedish Research Council and the Swedish Heart-Lung Foundation.
Publication
Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVIDBjörnson M, Wijnbladh K, Törnberg A, Svensson-Raskh A, Svensson A, Ståhlberg M, Runold M, Fedorowski A, Nygren Bonnier M, Bruchfeld J. Circulation: Arrhythmia and Electrophysiology, online 30 September 2025, doi: 10.1161/CIRCEP.124.013629.
Images
About Karolinska Institutet
Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Subscribe to releases from Karolinska Institutet - English
Subscribe to all the latest releases from Karolinska Institutet - English by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Karolinska Institutet - English
Simple test can predict risk of severe liver disease29.9.2025 09:00:00 CEST | Press Release
A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can predict the risk of developing severe liver disease. The method may already start to be applied in primary care to enable the earlier detection of cirrhosis and cancer of the liver.
Press invitation: Announcement of the Nobel Prize in Physiology or Medicine 202523.9.2025 13:00:00 CEST | Press Invitation
The Nobel Prize in Physiology or Medicine 2025 will be announced on Monday October 6 at 11.30 am CEST (at the earliest).
How mutations in bodily tissues affect ageing20.8.2025 11:00:00 CEST | Pressmeddelande
Two new studies from Karolinska Institutet in Sweden have investigated how mutations that occur in muscles and blood vessels over time can affect ageing. The studies, which are published in Nature Aging, show that such mutations can reduce muscle strength and accelerate blood vessel ageing. The results can be of significance to the treatment of age-related diseases.
New research confirms that neurons form in the adult brain3.7.2025 20:00:00 CEST | Pressmeddelande
A study in the journal Science presents compelling new evidence that neurons in the brain’s memory centre, the hippocampus, continue to form well into late adulthood. The research from Karolinska Institutet in Sweden provides answers to a fundamental and long-debated question about the human brain’s adaptability.
Gene therapy restored hearing in deaf patients2.7.2025 11:00:00 CEST | Pressmeddelande
Gene therapy can improve hearing in children and adults with congenital deafness or severe hearing impairment, a new study involving researchers at Karolinska Institutet reports. Hearing improved in all ten patients, and the treatment was well-tolerated. The study was conducted in collaboration with hospitals and universities in China and is published in the journal Nature Medicine.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

